7368 related articles for article (PubMed ID: 20375456)
1. A model of phospholipid biosynthesis in tumor in response to an anticancer agent in vivo.
Behzadi M; Demidem A; Morvan D; Schwartz L; Stepien G; Steyaert JM
J Integr Bioinform; 2010 Mar; 7(3):. PubMed ID: 20375456
[TBL] [Abstract][Full Text] [Related]
2. CENU treatment induced bystander effects which are effective on parental and non-parental tumors and have a phospholipid metabolism proton NMR spectroscopy signature.
Merle P; Morvan D; Madelmont JC; Caillaud D; Demidem A
Int J Oncol; 2006 Sep; 29(3):637-42. PubMed ID: 16865279
[TBL] [Abstract][Full Text] [Related]
3. Combined methionine deprivation and chloroethylnitrosourea have time-dependent therapeutic synergy on melanoma tumors that NMR spectroscopy-based metabolomics explains by methionine and phospholipid metabolism reprogramming.
Guénin S; Morvan D; Thivat E; Stepien G; Demidem A
Nutr Cancer; 2009; 61(4):518-29. PubMed ID: 19838924
[TBL] [Abstract][Full Text] [Related]
4. Melanoma tumors acquire a new phospholipid metabolism phenotype under cystemustine as revealed by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy of intact tumor samples.
Morvan D; Demidem A; Papon J; De Latour M; Madelmont JC
Cancer Res; 2002 Mar; 62(6):1890-7. PubMed ID: 11912170
[TBL] [Abstract][Full Text] [Related]
5. Quantitative HRMAS proton total correlation spectroscopy applied to cultured melanoma cells treated by chloroethyl nitrosourea: demonstration of phospholipid metabolism alterations.
Morvan D; Demidem A; Papon J; Madelmont JC
Magn Reson Med; 2003 Feb; 49(2):241-8. PubMed ID: 12541243
[TBL] [Abstract][Full Text] [Related]
6. DNA damage induced by a new 2-chloroethyl nitrosourea on malignant melanoma cells.
Godeneche D; Rapp M; Thierry A; Laval F; Madelmont JC; Chollet P; Veyre A
Cancer Res; 1990 Sep; 50(18):5898-903. PubMed ID: 2393861
[TBL] [Abstract][Full Text] [Related]
7. Cystemustine induces redifferentiation of primary tumors and confers protection against secondary tumor growth in a melanoma murine model.
Demidem A; Morvan D; Papon J; De Latour M; Madelmont JC
Cancer Res; 2001 Mar; 61(5):2294-300. PubMed ID: 11280801
[TBL] [Abstract][Full Text] [Related]
8. Metabolomics by proton nuclear magnetic resonance spectroscopy of the response to chloroethylnitrosourea reveals drug efficacy and tumor adaptive metabolic pathways.
Morvan D; Demidem A
Cancer Res; 2007 Mar; 67(5):2150-9. PubMed ID: 17332345
[TBL] [Abstract][Full Text] [Related]
9. A mathematical model to study the effects of drugs administration on tumor growth dynamics.
Magni P; Simeoni M; Poggesi I; Rocchetti M; De Nicolao G
Math Biosci; 2006 Apr; 200(2):127-51. PubMed ID: 16516246
[TBL] [Abstract][Full Text] [Related]
10. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
Falcioni R; Kennel SJ; Giacomini P; Zupi G; Sacchi A
Cancer Res; 1986 Nov; 46(11):5772-8. PubMed ID: 3756921
[TBL] [Abstract][Full Text] [Related]
11. Development of a syngenic brain-tumor model resistant to chloroethyl-nitrosourea using a methylguanine DNA methyltransferase cDNA.
Manome Y; Watanabe M; Futaki K; Ishiguro H; Iwagami S; Noda K; Dobashi H; Ochiai Y; Ohara Y; Sanuki K; Kunieda T; Ohno T
Anticancer Res; 1999; 19(6B):5313-8. PubMed ID: 10697554
[TBL] [Abstract][Full Text] [Related]
12. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
[TBL] [Abstract][Full Text] [Related]
13. N-(2-chloroethyl)-N-nitrosourea tethered to lexitropsin induces minor groove lesions at the p53 cDNA that are more cytotoxic than mutagenic.
Inga A; Chen FX; Monti P; Aprile A; Campomenosi P; Menichini P; Ottaggio L; Viaggi S; Abbondandolo A; Gold B; Fronza G
Cancer Res; 1999 Feb; 59(3):689-95. PubMed ID: 9973219
[TBL] [Abstract][Full Text] [Related]
14. The dynamics of cell proliferation.
Moxnes JF; Haux J; Hausken K
Med Hypotheses; 2004; 62(4):556-63. PubMed ID: 15050107
[TBL] [Abstract][Full Text] [Related]
15. Lack of phosphatidylethanolamine N-methyltransferase alters plasma VLDL phospholipids and attenuates atherosclerosis in mice.
Zhao Y; Su B; Jacobs RL; Kennedy B; Francis GA; Waddington E; Brosnan JT; Vance JE; Vance DE
Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1349-55. PubMed ID: 19520976
[TBL] [Abstract][Full Text] [Related]
16. Bystander effects are induced by CENU treatment and associated with altered protein secretory activity of treated tumor cells: a relay for chemotherapy?
Demidem A; Morvan D; Madelmont JC
Int J Cancer; 2006 Sep; 119(5):992-1004. PubMed ID: 16557598
[TBL] [Abstract][Full Text] [Related]
17. Phospholipid distribution in murine mammary adenocarcinomas induced by activated neu oncogene.
Monteggia E; Colombo I; Guerra A; Berra B
Cancer Detect Prev; 2000; 24(3):207-11. PubMed ID: 10975281
[TBL] [Abstract][Full Text] [Related]
18. Anticancer nitrosoureas: investigations on antineoplastic, toxic and neoplastic activities.
Eisenbrand G
IARC Sci Publ; 1984; (57):695-708. PubMed ID: 6533062
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of five xenografted human cancers and two murine cancers by the tripeptide tyroservatide.
Fu Z; Lu R; Jia J; Zhao L; Ma R; Lv JQ; Li XL; Chen LJ; Zhang HL; Wang L; Yao Z
Anticancer Drugs; 2007 Apr; 18(4):467-70. PubMed ID: 17351399
[TBL] [Abstract][Full Text] [Related]
20. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A
Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
